"I've never seen anything bigger"
According to one Wall Street Legend, "for those who take early action, it could make 2021 one of your best years ever".
Watch more here!

NVC Insider Trading (Neovasc)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): C$27,245.00
Insider Selling (Last 12 Months): C$0.00

Neovasc Insider Trading History Chart

Neovasc Share Price & Price History

▲ +0.04 (2.30%)
As of 03/10/2017 08:06 PM ET
Days: 30 | 90 | 365
The Next Big Winner in Heat-to-Eat Delivery
In partnership with TV celebrity chef Cat Cora, HBIS is an at-home dining start up that is firing on all cylinders to capitalize on the growing demand for prepared, heat-to-eat delivery meals.
Continue Reading

Neovasc Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/5/2021Paul GeyerDirectorBuy25,000C$1.09C$27,245.0098,333
6/12/2020Doug JanzenDirectorBuy100C$3.36C$336.00121,638
7/3/2019Paul GeyerDirectorSell5,357C$1.85C$9,910.45450
11/21/2018Paul GeyerDirectorSell5,343C$1.88C$10,025.50
See Full Table
Neovasc Inc. (Neovasc) is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Company's segment is the development, manufacture and marketing of medical devices. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina, and tissue products. The Tiara is in preclinical/early clinical stage development to provide a minimally invasive transcatheter device for patients experiencing mitral regurgitation (MR) as a result of mitral heart valve disease. The Reducer is an hourglass-shaped, balloon-expandable, stainless steel, bare metal device, which is implanted in the coronary sinus, creating a restriction in venous outflow from the myocardium (the muscular layer of the heart wall). Neovasc produces Peripatch, a biological tissue product that is manufactured from pericardium.
Read More on Neovasc

Today's Range

Now: C$1.78

50 Day Range


52 Week Range

Now: C$1.78


46,869 shs

Average Volume

111,876 shs

Market Capitalization

C$140.06 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Neovasc?

Neovasc's top insider investors include:
  1. Doug Janzen (Director)
  2. Paul Geyer (Director)
This Is By Far My #1 Income Stock
This company owns the bestselling drug in the world, which brought in $19.9 billion in revenue last year. And today, I want to give you the name, the ticker symbol and my full analysis completely free - no strings attached.
Click here to get it.